Skip to main content

Table 2 Demographic data on the groups A (MYBPC3 IVS20-2A>G) and B (all other mutations carriers)

From: A human MYBPC3 mutation appearing about 10 centuries ago results in a hypertrophic cardiomyopathy with delayed onset, moderate evolution but with a risk of sudden death

 

Group A

Group B

Subjects (n)

34

73

Families (n)

9

36

Women (n)

23 (67.6%)

38 (52.1%)

Patients with HCM (n)

21 (61.8%)

49 (67.1%)

Symptomatic carriers (n)

23 (67.6%)

49 (67.1%)

Average age at last visit (year)

47.28*

39.07

  1. *: p < 0.05.